Antipsychotics and obsessive–compulsive disorder/obsessive–compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system

BG Burk, T DiGiacomo, S Polancich… - Acta Psychiatrica …, 2023 - Wiley Online Library
Objective Antipsychotics have conflicting data with respect to obsessive–compulsive
disorder/symptoms (OCD/OCS), with some reporting causality and some reporting treatment …

Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019

S Oh, S Byeon, SJ Chung - Journal of Psychopharmacology, 2022 - journals.sagepub.com
Background: Retrospective studies using spontaneous reporting system databases have
provided a great understanding of adverse drug reactions (ADRs) in the real world …

Induced obsessive compulsive symptoms (OCS) in schizophrenia patients under atypical 2 antipsychotics (AAPs): review and hypotheses

DG Laroche, A Gaillard - Psychiatry Research, 2016 - Elsevier
The prevalence of OCS and OCD is higher in schizophrenic patients than in the general
population. These disorders are sometimes induced by AAPs. There is higher frequency of …

Aripiprazole versus quetiapine in treatment-resistant obsessive–compulsive disorder: a double-blind clinical trial

S Shoja Shafti, H Kaviani - Therapeutic advances in …, 2015 - journals.sagepub.com
Introduction: Around 40–60% of the patients with obsessive–compulsive disorder (OCD)
remain unimproved by serotonin reuptake inhibitors (SRIs). Goal of this study was to …

Aripiprazole augmentation in treatment-refractory obsessive–compulsive disorder

R Sarkar, J Klein, S Krüger - Psychopharmacology, 2008 - Springer
Discussion This case report suggests that combining escitalopram and aripiprazole can
significantly improve treatment-refractory OCD. The selective response of OCD patients to …

Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a 12-week open-label preliminary study

E Pessina, U Albert, F Bogetto… - International clinical …, 2009 - journals.lww.com
One of the most studied and well-documented strategies for treatment-resistant obsessive–
compulsive disorder (OCD) is the addition of antipsychotic drugs to the ongoing serotonin …

[HTML][HTML] Safety profile of antipsychotic drugs: analysis based on a provincial spontaneous reporting systems Database

K Guo, Z Feng, S Chen, Z Yan, Z Jiao… - Frontiers in …, 2022 - frontiersin.org
Introduction: Antipsychotic drugs are the main therapy for schizophrenia and have been
widely used in mental disorder fields. However, the research on the safety of antipsychotic …

[HTML][HTML] A cross sectional study of impact and clinical risk factors of antipsychotic-induced OCD

M Biria, FX Huang, Y Worbe, NA Fineberg… - European …, 2019 - Elsevier
A large proportion of schizophrenia patients treated with second generation antipsychotics
will develop Obsessive Compulsive Disorder (OCD). However, there are few studies about …

Fluoxetine adjunctive therapy for obsessive-compulsive symptoms associated with olanzapine in schizophrenic patients

T Figueiredo, D Segenreich… - Journal of Clinical …, 2016 - journals.lww.com
To the Editors: The prevalence of patients with schizo-phrenia exhibiting obsessive-
compulsive symptoms (OCS) is estimated at approximately 30%. 1 Approximately 12% of …

Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study

SW Kim, IS Shin, JM Kim, SJ Yang… - Journal of clinical …, 2008 - journals.lww.com
Obsessive-compulsive symptoms (OCSs) are frequently comorbid with schizophrenia. For
more than a century, OCSs during the course of schizophrenia have been described in …